IKT Inhibikase Therapeutics announces FDA orphan drug designation granted to ikt-001 for the treatment of pah
IKT Inhibikase Therapeutics announces FDA orphan drug designation granted to ikt-001 for the treatment of pah
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.